(19)
(11) EP 4 816 390 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24817538.2

(22) Date of filing: 29.11.2024
(51) International Patent Classification (IPC): 
C07K 14/575(2006.01)
A61K 38/08(2019.01)
A61K 38/26(2006.01)
A61P 1/16(2006.01)
A61P 3/04(2006.01)
A61P 43/00(2006.01)
C07D 401/14(2006.01)
C07K 7/06(2006.01)
C07K 14/585(2006.01)
 A61K 38/00(2006.01)
A61K 38/16(2006.01)
A61P 1/04(2006.01)
A61P 3/00(2006.01)
A61P 3/10(2006.01)
C07D 401/12(2006.01)
C07D 471/04(2006.01)
C07K 7/08(2006.01)
C07K 14/605(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/08; C07K 14/575; C07K 14/605; C07K 7/06; C07K 7/08; C07K 14/585; A61K 38/26; A61P 3/04
(86) International application number:
PCT/EP2024/084031
(87) International publication number:
WO 2025/114501 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.11.2023 EP 23213366

(71) Applicant: Novo Nordisk A/S
2880 Bagsværd (DK)

(72) Inventors:
  • KRUSE, Thomas
    2880 Bagsværd (DK)
  • LAU, Jesper F.
    2880 Bagsværd (DK)
  • FRICH, Camilla Kaas
    2880 Bagsværd (DK)
  • MADSEN, Charlotte Stahl
    2880 Bagsværd (DK)
  • HAXVIG, Christina Sophie
    2880 Bagsværd (DK)
  • BEHRENS, Carsten
    2880 Bagsværd (DK)

   


(54) TRI-AGONISTS OF THE GLP-1, GIP, AND AMYLIN RECEPTORS